Completed PHASE3 INTERVENTIONAL 2-arm NCT01270048

The Effect of Bunsimgieum on the Chest Discomfort of Hwa-byung's Major Symptom

The Effect of Bunsimgi-eum(Fenxinqiyin) on the Chest Discomfort of Hwa-byung's Major Symptom : Randomized, Double-blinded, Placebo-control Trial

Sponsor: Korea Health Industry Development Institute

Conditions Hwa-byung (Disorder)

Interventions Placebo mild-ex-gwarip

Updated 5 times since 2017 Last updated: Jan 4, 2011 Started: May 31, 2008 Primary completion: Mar 31, 2009 Completion: Aug 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hwa-byung (Disorder), this trial is completed. The trial is conducted by Korea Health Industry Development Institute and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Korea Health Industry Development Institute

Data source: Korea Health Industry Development Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Daejeon, South Korea